ARCHIVES

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

Robert Day Advocates NCI Payment for Investigator Salaries

May 7, 1999

NCI Director May Alert Cancer Panel to Freeze On GS-13 Promotion

November 4, 1994

Einhorn Sees More Results Coming Similar to Big Successes in Testicular Cancer

May 15, 1981

Alternative to Animal Use In Research Outlined By OTA

February 21, 1986

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

CPSC Relies On NCI Findings For New Policy

July 21, 1978